Published in AJR Am J Roentgenol on November 01, 2002
Classification of dynamic contrast-enhanced magnetic resonance breast lesions by support vector machines. IEEE Trans Med Imaging (2008) 1.73
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg (2006) 1.70
Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort. Magn Reson Imaging (2009) 1.56
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology (2010) 1.33
In vivo breast sound-speed imaging with ultrasound tomography. Ultrasound Med Biol (2009) 1.24
Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer (2004) 1.18
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol (2010) 1.17
Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. Br J Cancer (2008) 1.15
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights Imaging (2013) 1.14
Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol (2010) 1.08
Monitoring therapeutic efficacy in breast carcinomas. Eur Radiol (2006) 1.03
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. Cancer (2009) 1.00
Imaging in breast cancer: magnetic resonance imaging. Breast Cancer Res (2005) 1.00
Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy. Transl Oncol (2012) 1.00
High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Acad Radiol (2011) 1.00
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer. Br J Cancer (2009) 0.95
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results. Magn Reson Imaging (2013) 0.94
Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy. Korean J Radiol (2011) 0.94
Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed. Med Phys (2009) 0.90
MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy. PLoS One (2013) 0.90
Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer (2012) 0.89
Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg (2009) 0.87
A high spatial resolution 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time. Magn Reson Imaging (2007) 0.87
Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. Breast Cancer (Dove Med Press) (2012) 0.87
Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol (2013) 0.87
Breast imaging in the new era. Cancer Imaging (2004) 0.86
Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy. Br J Cancer (2013) 0.84
Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy. Eur Radiol (2010) 0.83
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response. Acad Radiol (2013) 0.83
MR imaging of the breast: indications, established technique, and new directions. Eur Radiol (2003) 0.82
Modern breast cancer detection: a technological review. Int J Biomed Imaging (2009) 0.82
Accuracy of MRI volume measurements of breast lesions: comparison between automated, semiautomated and manual assessment. Eur Radiol (2009) 0.82
Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy. J Magn Reson Imaging (2013) 0.81
Quantification of background enhancement in breast magnetic resonance imaging. J Magn Reson Imaging (2011) 0.80
PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilities. J Inorg Biochem (2011) 0.80
MRI for breast cancer: Current indications. Indian J Radiol Imaging (2009) 0.80
Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy. Biomed Res Int (2013) 0.79
Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.79
Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer? J Oncol (2013) 0.78
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer (2015) 0.78
Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol (2016) 0.78
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype. Springerplus (2016) 0.77
Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes. PLoS One (2016) 0.77
Early prediction of response to neoadjuvant chemotherapy for locally advanced breast cancer using MRI. Nagoya J Med Sci (2011) 0.76
Intraoperative micro-computed tomography (micro-CT): a novel method for determination of primary tumour dimensions in breast cancer specimens. Br J Radiol (2015) 0.75
Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit. J Oncol (2010) 0.75
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype. Oncologist (2017) 0.75
A comparison study between gross tumor volumes defined by preoperative magnetic resonance imaging, postoperative specimens, and tumor bed for radiotherapy after breast-conserving surgery. Medicine (Baltimore) (2017) 0.75
NEO adjuvant chemotherapy in breast cancer: What have we learned so far? Indian J Med Paediatr Oncol (2010) 0.75
Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection. Br J Radiol (2014) 0.75
Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects. Springerplus (2014) 0.75
The yeast cell-cycle network is robustly designed. Proc Natl Acad Sci U S A (2004) 6.76
Sequence and analysis of rice chromosome 4. Nature (2002) 4.39
On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am J Hum Genet (2008) 3.95
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med (2014) 3.78
Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. J Bone Miner Res (2004) 3.77
Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology (2003) 3.36
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology (2004) 3.24
Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11
The UCSC Cancer Genomics Browser. Nat Methods (2009) 3.08
Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol (2009) 2.97
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc Natl Acad Sci U S A (2005) 2.59
Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage (2004) 2.58
Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology (2007) 2.48
The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg (2012) 2.37
Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology (2002) 2.26
Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol (2003) 2.16
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users. Cancer Epidemiol Biomarkers Prev (2008) 2.12
Breast cancer growth prevention by statins. Cancer Res (2006) 2.09
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol (2005) 2.06
Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol (2002) 1.99
Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol (2004) 1.98
Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A (2011) 1.97
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. Cancer Prev Res (Phila) (2010) 1.91
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. J Exp Med (2012) 1.85
New two-dimensional metal-organic networks constructed from 1,2,4,5-benzenetetracarboxylate and chelate ligands. Inorg Chem (2003) 1.83
Distinguishing features of self-limiting adult small-bowel intussusception identified at CT. Radiology (2003) 1.76
Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol (2008) 1.74
Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA (2010) 1.71
Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg (2010) 1.70
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology (2004) 1.69
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol (2005) 1.69
Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations. Anesthesiology (2003) 1.69
The draft genome of the fast-growing non-timber forest species moso bamboo (Phyllostachys heterocycla). Nat Genet (2013) 1.68
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology (2002) 1.68
Designing verbal autopsy studies. Popul Health Metr (2010) 1.64
Transit-amplifying cell frequency and cell cycle kinetics are altered in aged epidermis. J Invest Dermatol (2009) 1.57
Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum (2011) 1.55
Adaptation of the proximal femur to skeletal reloading after long-duration spaceflight. J Bone Miner Res (2006) 1.55
Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol (2014) 1.50
Comparing BMD results between two similar DXA systems using the generalized least significant change. J Clin Densitom (2008) 1.48
Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg (2002) 1.47
Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging (2004) 1.47
Comparison of bootstrap approaches for estimation of uncertainties of DTI parameters. Neuroimage (2006) 1.47
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. J Am Coll Surg (2009) 1.46
Tractography-based quantitation of diffusion tensor imaging parameters in white matter tracts of preterm newborns. J Magn Reson Imaging (2005) 1.46
Sodium channel genes and the evolution of diversity in communication signals of electric fishes: convergent molecular evolution. Proc Natl Acad Sci U S A (2006) 1.45
MRI and CT of insufficiency fractures of the pelvis and the proximal femur. AJR Am J Roentgenol (2008) 1.44
Selective inflammatory pain insensitivity in the African naked mole-rat (Heterocephalus glaber). PLoS Biol (2008) 1.43
Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J (2006) 1.43
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat (2010) 1.42
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res (2008) 1.42
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42
Old gene duplication facilitates origin and diversification of an innovative communication system--twice. Proc Natl Acad Sci U S A (2010) 1.41
Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer (2004) 1.40
Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg (2009) 1.39
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed (2006) 1.38
Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn (2011) 1.37
Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. J Clin Oncol (2002) 1.37
Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J Mol Biol (2005) 1.36
Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology (2004) 1.36
Comparing microstructural and macrostructural development of the cerebral cortex in premature newborns: diffusion tensor imaging versus cortical gyration. Neuroimage (2005) 1.36
Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci (2005) 1.35
Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol (2006) 1.34
Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther (2003) 1.33
Gene duplications and evolution of vertebrate voltage-gated sodium channels. J Mol Evol (2006) 1.32
Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS (2009) 1.32
Complete genome sequence of Lactococcus lactis subsp. lactis CV56, a probiotic strain isolated from the vaginas of healthy women. J Bacteriol (2011) 1.31
Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke (2004) 1.31
Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom (2006) 1.30
Toxin-resistant sodium channels: parallel adaptive evolution across a complete gene family. Mol Biol Evol (2008) 1.29
Map-based cloning and characterization of a gene controlling hairiness and seed coat color traits in Brassica rapa. Plant Mol Biol (2008) 1.29
Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology (2007) 1.29
Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr (2007) 1.28
Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis (2007) 1.27
Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis. Radiology (2005) 1.27
Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol (2010) 1.27
The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol (2005) 1.26
A fine physical map of the rice chromosome 4. Genome Res (2002) 1.26
Microbial abundance and composition influence litter decomposition response to environmental change. Ecology (2013) 1.24
CT signs of hepatofugal portal venous flow in patients with cirrhosis. AJR Am J Roentgenol (2003) 1.24
Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg (2008) 1.24
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging (2007) 1.21
Diagnostic performance of in vivo 3-T MRI for articular cartilage abnormalities in human osteoarthritic knees using histology as standard of reference. Eur Radiol (2008) 1.17
MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology (2011) 1.17
Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed (2004) 1.17
Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat (2011) 1.17
The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells. PLoS One (2012) 1.16
Performance of four computer-coded verbal autopsy methods for cause of death assignment compared with physician coding on 24,000 deaths in low- and middle-income countries. BMC Med (2014) 1.15
Optimizing the total skin-sparing mastectomy. Arch Surg (2008) 1.14
Expanding the reach of decision and communication aids in a breast care center: a quality improvement study. Patient Educ Couns (2010) 1.14